Cardiovascular disease remains a leading cause of premature mortality in Europe. Early identification of risk factors enables clinicians and patients to implement behavioural and therapeutic interventions that can reduce risk and promote healthier living. Emerging biomarkers, such as lipoprotein(a), offer valuable insights into subclinical cardiovascular risk.
Questionnaire
N/A
Measurements
Mandatory: N/A
Non-mandatory: N/A
Laboratory
Mandatory: Lipoprotein(a)
Non-mandatory: N/A
Interpretations
Flag assignment and report content are generated to reflect the relevant combinations of data inputs from laboratory results.🟢 Green flag: Indicates a normal lipoprotein(a)
🟡 Amber flag: Indicates an intermediate lipoprotein(a)
🔴 Red flag: Indicates a high lipoprotein(a)